List view / Grid view


MISSION Therapeutics receives funding for DUB cancer programme

24 September 2015 | By Victoria White

Deubiquitylating enzymes (DUBs) are involved in multiple cellular processes, including DNA damage and cell proliferation, and the inhibition of these enzymes has considerable potential for the generation of novel drugs...

NIHS and AC Immune to develop Alzheimer’s diagnostic

23 September 2015 | By Victoria White

The collaboration will develop a sensitive, minimally invasive Tau diagnostic assay for early Alzheimer’s disease by applying Nestlé’s multiplexed ultrasensitive antibody technology platform...

Inovio receives $24m grant to advance Ebola programme

21 September 2015 | By Victoria White

DARPA is to provide the additional $24 million after Inovio successfully completed certain preclinical and clinical development milestones relating to the Ebola treatment programme...

BerGenBio presents positive preclinical data on BGB324

21 September 2015 | By Victoria White

The data highlights that BGB324 used in combination with immune checkpoint inhibitors in mouse carcinoma models showed enhanced tumour clearance compared with checkpoint inhibition alone...

Selvita expands its operations into the US

21 September 2015 | By Victoria White

Appreciating the importance of the US biotechnology and pharmaceutical market, Selvita decided to come closer to its partners and clients and open a fully-owned US subsidiary, Selvita Inc...